NEW YORK (GenomeWeb News) – Complete Genomics said today that its revenues increased 74 percent year over year during the third quarter.

For the three months ended Sept. 30, revenues reached $7.3 million, compared to $4.2 million a year ago. Despite the spike, the Mountain View, Calif.-based company, which is in the process of being acquired by BGI-Shenzhen, missed the average analyst estimate of $8.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.